| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $1.5 (Beat by $0.3) |
| EPS GAAP Actual | $1.5 (Beat by $0.3) |
| Revenue Actual | $1.86869B |
| Revenue Surprise | Beat by $1868.69M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.405 |
| EPS GAAP Estimate | $0.405 |
| Revenue Estimate | $0.62B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.9 | 48.57 | 2.05013 | 4.05452 | 1 |
| Dec 2028 | -1.99 | -70.78 | -2.41544 | -1.26955 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.65 | 0.65873 | 1.86869B | 39.6% | 391.56M |
| FQ2 2025 (Jun 2025) | 5.6 | 5.384 | 1.49721B | 3.18% | 440.39M |
| FQ1 2025 (Mar 2025) | 0.26 | 0.26 | 2.0343B | 19.5% | 2034.3M |
| FQ4 2024 (Dec 2024) | 5.13 | 5.13 | 2.27164B | 58.01% | 2271.64M |
| FQ3 2024 (Sep 2024) | 0.3 | 0.3 | 1.1286B | 100% | 1128.6M |
| FQ1 2019 (Mar 2019) | 0 | 0 | 0.135495B | 100% | 135.5M |
| FQ2 2019 (Jun 2019) | 0 | 0 | 0.135495B | 100% | 135.5M |
| FQ3 2019 (Sep 2019) | -0.15 | -0.15 | 0.125911B | 100% | 125.91M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.405
Consensus Revenue Estimates
0.62B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.50667 | -- | 1.36639 | 1.62218 | 8 |
| FQ3 2027 (Sep 2027) | 0.99 | -- | 0.99 | 0.99 | 8 |
| FQ2 2027 (Jun 2027) | 1.03 | -- | 1.03 | 1.03 | 5 |
| FQ1 2027 (Mar 2027) | 1.37667 | -- | 1.2485 | 1.48221 | 8 |
| FQ4 2026 (Oct 2026) | 0.49 | -- | 0.38919 | 0.65318 | 3 |
| FQ3 2026 (Jul 2026) | 0.45 | -266.67 | 0.35742 | 0.59986 | 3 |
| FQ2 2026 (Jun 2026) | 0.34 | -1547.06 | 0.27336 | 0.4503 | 3 |
| FQ1 2026 (Mar 2026) | 0.405 | 35.8 | 0.32561 | 0.53639 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.91B | -- | 1.77B | 2.02B | 8 |
| FQ3 2027 (Sep 2027) | 1.53B | -- | 1.53B | 1.53B | 6 |
| FQ2 2027 (Jun 2027) | 1.56B | -- | 1.56B | 1.56B | 6 |
| FQ1 2027 (Mar 2027) | 1.86B | -- | 1.73B | 1.97B | 8 |
| FQ4 2026 (Oct 2026) | 0.73B | -- | 0.61B | 0.91B | 8 |
| FQ3 2026 (Jul 2026) | 0.74B | -151.51 | 0.63B | 0.93B | 5 |
| FQ2 2026 (Jun 2026) | 0.6B | -149.54 | 0.51B | 0.75B | 5 |
| FQ1 2026 (Mar 2026) | 0.62B | -228.11 | 0.53B | 0.77B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.99127 | 1.65 | 0.65873 | 39.92% |
| FQ2 2025 (Jun 2025) | 0.216 | 5.6 | 5.384 | 96.14% |
| FQ1 2025 (Mar 2025) | 0.26 | 0.26 | 100% | |
| FQ4 2024 (Dec 2024) | 5.13 | 5.13 | 100% | |
| FQ3 2024 (Sep 2024) | 0.3 | 0.3 | 100% | |
| FQ1 2019 (Mar 2019) | 0 | 0 | NAN% | |
| FQ2 2019 (Jun 2019) | 0 | 0 | NAN% | |
| FQ3 2019 (Sep 2019) | -0.15 | -0.15 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.48B | $1.87B | $391.56M | 20.95% |
| FQ2 2025 (Jun 2025) | $1.06B | $1.5B | $440.39M | 29.41% |
| FQ1 2025 (Mar 2025) | $0B | $2.03B | $2034.3M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.27B | $2271.64M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.13B | $1128.6M | 100% |
| FQ1 2019 (Mar 2019) | $0B | $0.14B | $135.5M | 100% |
| FQ2 2019 (Jun 2019) | $0B | $0.14B | $135.5M | 100% |
| FQ3 2019 (Sep 2019) | $0B | $0.13B | $125.91M | 100% |